Sponsor pipeline

Actuate Therapeutics Inc. clinical trial pipeline

Get alerts when Actuate Therapeutics Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1/2
1
Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT03678883 9-ING-41 in Patients With Advanced Cancers Cancer Active, Not Recruiting 2026-04-03
Phase 1/2
NCT07714395 Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With… Advanced Malignant Solid Tumor Not Yet Recruiting 2026-07-20

Disease areas by active trials

Breast Cancer (1) · Colorectal Cancer (1) · Glioma (1) · Kidney Cancer (1) · Leukemia (1) · Lung Cancer (1) · Non-Hodgkin Lymphoma (1) · Pancreatic Cancer (1) · Sarcoma (1)

Get alerts when Actuate Therapeutics Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free